SEC Form 4 · accession 0000880771-16-000190
SCICLONE PHARMACEUTICALS INC · SCLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nancy T Chang
Director
Period of report
Aug 26, 2016
Accepted (ET)
Aug 30, 2016 · 4:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880771
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 26, 2016 | S | 7,500 | $10.2521 | D | 17,540 | I | by Partnership |
| Common Stock | Aug 29, 2016 | S | 10,000 | $10.3119 | D | 7,540 | I | by Partnership |
| Common Stock | Aug 30, 2016 | S | 7,540 | $10.3298 | D | 0 | I | by Partnership |
| Common Stock | holding | — | — | — | 29,019 | D |
Table II — derivative securities
No Table II lines on this filing.